MicroDose Therapeutx (formerly MicroDose Technologies Inc)
4262 US Route 1
Monmouth Junction
New Jersey
08852
United States
Tel: 732-355-2100
Fax: 732-355-2101
Website: http://www.microdose-tech.com/
22 articles about MicroDose Therapeutx (formerly MicroDose Technologies Inc)
-
Microdose Psychedelic Insights: 2020 Year in Review for the Psychedelic OS
11/30/2020
While the coronavirus pandemic brought unforeseen global challenges in 2020, the psychedelic renaissance repeatedly garnered historic victories.
-
Teva Pharmaceutical Industries Limited Bags MicroDose Therapeutx (formerly MicroDose Technologies Inc) for $165 Million
6/17/2013
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Successful Conclusion of Safety Study in Asthmatic Patients for MDT-637 and Presentation of Overall Phase 1 Results at the 8th Annual International Respiratory Syncytial Virus (RSV) Symp
9/28/2012
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) and Moerae Matrix Announce Collaboration to Develop Novel Inhaled Treatment for Idiopathic Pulmonary Fibrosis (IPF)
6/20/2012
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Conclusion of MDT-637 Phase I Single and Multiple Ascending Dose Studies in Healthy Volunteers for Treatment of Respiratory Syncytial Virus (RSV)
4/24/2012
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Begins Phase 1 Trial of MDT-637 for Treatment of Respiratory Syncytial Virus
9/27/2011
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Successful Completion of Phase 1 Pilot Study with Inhaled Atropine as Antidote to Combat Effects of Nerve Agent Poisoning
6/7/2011
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Achievement of Development Milestone Triggering a Payment Under Respiratory Collaboration
5/2/2011
-
Gilead Sciences, Inc., MicroDose Therapeutx (formerly MicroDose Technologies Inc) Ink License Deal For MDT-637
4/20/2011
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) and Nexus6 Announce Worldwide Partnership to Commercialize the SmartInhalerLiveTM Technology with MicroDose's Electronic Dry Powder Inhalers
11/9/2010
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Awarded Four Therapeutic Discovery Grants Totaling Approximately $1 Million
11/4/2010
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) to Present at the 30th Annual Cowen and Company Healthcare Conference on Tuesday, March 9th
3/4/2010
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Acquires EPIX Pharmaceuticals, Inc. Portfolio of Compounds for Treatment of Chronic Constipation and Irritable Bowel Syndrome with Constipation (IBS-C)
12/1/2009
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Acquires ViroPharma Incorporated Portfolio of Investigational Compounds for Treatment of Respiratory Syncytial Virus (RSV)
11/9/2009
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Initiation of Phase 1 Study with Inhaled Atropine as Antidote to Combat Effects of Nerve Agent Poisoning
9/23/2009
-
MicroDose Therapeutx (formerly MicroDose Technologies Inc) Announces Expansion of Collaboration with Merck & Co., Inc. for Dry Powder Inhaler Technology
7/22/2009
-
MicroDose Technologies Becomes MicroDose Therapeutx: Name Change Reflects Expanded Vision and Opportunities
4/27/2009
-
MicroDose Technologies Inc and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler
1/7/2009
-
MicroDose Technologies Inc Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
8/5/2008
-
MicroDose Technologies Inc Grants Global License to Merck & Co., Inc. for Use of the MicroDose Inhaler with Merck's Proprietary Products
3/3/2008